Nexalin Technology (NXL) Share-based Compensation (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly Share-based Compensation of $169000.0 in Q1 2026, up 127.9% quarter-over-quarter from -$605734.0 in Q4 2025, and down 28.09% on a YoY basis from $235000.0 in Q1 2025.
Nexalin Technology (NXL) Share-based Compensation (2021 - 2026) Analysis & Trends
Nexalin Technology's Share-based Compensation history runs 6 years deep, the most recent figure standing at $169000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 28.09% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $881407.0 (down 75.75% YoY), while the FY2025 annual figure was $1.7 million, down 52.65% from the prior year.
- Share-based Compensation was $169000.0 for Q1 2026 at Nexalin Technology, up from -$605734.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.4 million in Q4 2023 to a low of -$605734.0 in Q4 2025.
- Historically, Share-based Compensation has averaged $580283.2 across 5 years, with a median of $235000.0 in 2025.
- Biggest YoY gain for Share-based Compensation was 45.65% in 2025; the steepest drop was 139.04% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $184291.0 in 2022, then surged by 1209.55% to $2.4 million in 2023, then sank by 35.7% to $1.6 million in 2024, then plunged by 139.04% to -$605734.0 in 2025, then surged by 127.9% to $169000.0 in 2026.
- The last three Share-based Compensation figures came in at $169000.0 (Q1 2026), -$605734.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | -605,734.00 |
| Dec 31, 2025 | -605,734.00 |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 235,351.00 |
| Jun 30, 2025 | 235,351.00 |
| Mar 31, 2025 | 235,000.00 |
| Mar 31, 2025 | 235,000.00 |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 308,283.00 |
| Jun 30, 2024 | 308,283.00 |
| Mar 31, 2024 | 161,349.00 |
| Mar 31, 2024 | 161,349.00 |
| Dec 31, 2023 | 2.41 Mn |
| Dec 31, 2023 | 2.41 Mn |